Common Contracts
5 similar Inducement Option Award Agreement contracts by ProPhase Labs, Inc.
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 20th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 1st day of January 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Jed Latkin (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 20th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 15th day of April 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Lance Bisesar (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 9th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 1st day of January 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Jed Latkin (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • December 1st, 2021 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 19th day of November, 2021 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Samad Beeler (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • August 23rd, 2021 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 10th day of August, 2021 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Kamal Obbad (hereinafter called the “Optionee”):
